| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 09/18/2013 | CN103301479A Method for assessing acute toxicity of medicament by using model animal zebrafish fries |
| 09/18/2013 | CN103301478A Novel mixed type cornea and conjuctiva intravital staining agent |
| 09/18/2013 | CN103301460A Ferroferric oxide loaded compound micropowder and application thereof |
| 09/18/2013 | CN102295926B Fluorescent mesoporous silicon oxide nanomaterial and preparation method and application thereof |
| 09/18/2013 | CN101829120B Composition for treatment of external secretion disorders |
| 09/18/2013 | CN101678128B 磁共振成像 Magnetic Resonance Imaging |
| 09/17/2013 | US8535684 Methods of inhibiting HIV infectivity |
| 09/17/2013 | US8535678 Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 09/17/2013 | US8535644 Tunable hydrogel microparticles |
| 09/17/2013 | US8535642 Contrast agents |
| 09/17/2013 | US8535641 Phospholipid analogs as diapeutic* agents and methods thereof |
| 09/17/2013 | CA2563887C Mite allergen zen 1 |
| 09/17/2013 | CA2516519C Animal model for the fast identification of pharmaceutical active compounds in vivo |
| 09/12/2013 | WO2013134342A1 Methods and kits for detecting non-luminescent or weakly luminescent metals |
| 09/12/2013 | WO2013132396A1 Coloring substance for diagnostic ophtalmologic use |
| 09/12/2013 | WO2013132252A1 Diagnostic marker compounds and their use |
| 09/12/2013 | WO2013131994A2 Coating for the diagnosis of inflammatory tissues in dental applications |
| 09/12/2013 | WO2013131993A2 Device for the diagnosis of inflammatory tissues in dental applications |
| 09/12/2013 | WO2013131884A1 Dynamic contrast enhanced mri method and agents for the assessment of the macromolecular transport within pathologic tissues |
| 09/12/2013 | WO2013103301A3 Method for preparing cell targeting conjugates, and the complexes obtained |
| 09/12/2013 | US20130239235 Methods for testing for caloric restriction (cr) mimetics |
| 09/12/2013 | US20130239234 Phosphodiesterase activity and regulation of phosphodiesterase 1b-mediated signaling in brain |
| 09/12/2013 | US20130233748 Abuse Potential Reduction in Abusable Substance Dosage Form |
| 09/11/2013 | EP2636748A1 Amino sugar-containing glucan, method for producing same and use of same |
| 09/11/2013 | EP2635311A1 Cest systems exhibiting a concentration independent responsiveness |
| 09/11/2013 | CN103290695A Method for one-step realization of water stability treatment and functional modification of gamma-PGA nano fiber |
| 09/11/2013 | CN103290019A Atherosclerosis targeting aptamer as well as preparation method and application thereof |
| 09/11/2013 | CN103290017A HER2 (Human Epidermal Growth Factor Receptor 2) protein nucleotide aptamer, complex composition and applications thereof |
| 09/11/2013 | CN103289674A Water-soluble up-conversion luminescence nano material based on triplet state-triplet state annihilation and preparation method and application thereof |
| 09/11/2013 | CN103288935A Polypeptides |
| 09/11/2013 | CN103288061A Bismuth selenide nanometer material, preparation method and applications thereof |
| 09/11/2013 | CN103285411A Preparation method of poly(lactic-co-glycolic acid based magnetic medicine-carrying hollow microspheres |
| 09/11/2013 | CN103285410A Synthesis method of lectin-iron core gold shell nanoparticles for tumor MRI/CT dual-mode diagnosis |
| 09/11/2013 | CN103285409A An MRI / up-conversion fluorescence dual-mode imaging contrast agent having chemotherapy / radiotherapy synergies and a preparation method thereof |
| 09/11/2013 | CN103285408A Application of FITC-dextran in manufacturing fundus angiographic agent |
| 09/11/2013 | CN102743646B Medicinal composition for inspecting and preventing diabetes |
| 09/11/2013 | CN102552945B Surface modification method of magnetic iron oxide nano-particles |
| 09/11/2013 | CN102038963B Method for preparing a stabilised menthol emulsion |
| 09/11/2013 | CN101790386B Clustered magnetic particles as tracers for magnetic particle imaging |
| 09/10/2013 | US8530635 Cupredoxin derived transport agents and methods of use thereof |
| 09/10/2013 | US8529900 Methods for the treatment, the prognostic assessment and the staging of non-small cell lung cancer |
| 09/10/2013 | US8529898 Activatable binding polypeptides and methods of identification and use thereof |
| 09/10/2013 | CA2529027C D-amino acid peptides |
| 09/10/2013 | CA2331789C Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 09/06/2013 | WO2013130881A1 Methods for the production, modification and use of metallic nanoparticles |
| 09/06/2013 | WO2013130449A1 Phosphoramidite compositions |
| 09/06/2013 | WO2013130354A1 Targeted treatment of anerobic cancer |
| 09/06/2013 | WO2013130177A1 Psma as a biomarker for androgen activity in prostate cancer |
| 09/06/2013 | WO2013127912A1 Superparamagnetic nanoparticles with peg substituted alpha-hydroxy phosponate shells |
| 09/05/2013 | US20130230468 Isotopically labeled deoxy-glucose and derivatives thereof, compositions comprising them and uses thereof |
| 09/05/2013 | US20130230467 Polymerized micelles for diagnosis |
| 09/05/2013 | US20130230465 Benzocyanine compounds |
| 09/05/2013 | US20130230464 Imaging Probe Including Nanoparticle |
| 09/05/2013 | US20130230463 SUPERPARAMAGNETIC NANOPARTICLES WITH PEG SUBSTITUTED alpha-HYDROXY PHOSPHONATE SHELLS |
| 09/05/2013 | US20130230456 Papillomavirus pseudoviruses for detection and therapy of tumors |
| 09/05/2013 | US20130230455 Use of gelsolin to treat multiple sclerosis and to diagnose neurologic diseases |
| 09/05/2013 | US20130230454 Therapeutic Angiogenesis for Treatment of the Spine and Other Tissues |
| 09/05/2013 | US20130230453 Diagnosis and treatment of brain tumors |
| 09/04/2013 | EP2632939A2 Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis |
| 09/04/2013 | EP2632489A2 Compositions targeting the soluble extracellular domain of e-cadherin and related methods for cancer therapy |
| 09/04/2013 | CN103282056A Radial shape of polymer compound containing iodine, preparation method thereof, and ct contrast medium composition containing same |
| 09/04/2013 | CN103275722A Magneto-optical bimodal imaging probe rare earth nanoparticle, and preparation method and application thereof |
| 09/04/2013 | CN103275712A Preparation method and application of double-mode molecular probe based on gadolinium doped carbon point |
| 09/04/2013 | CN103275351A Crosslinking agent and cross-linked polymer as well as preparation method and application thereof |
| 09/04/2013 | CN103275212A Antihuman CD146 monoclone antibody, composition containing same, and method for testing dissolubility CD146 |
| 09/04/2013 | CN103274397A Synthetic method of lanthanide metal loaded fullerene nanomaterial water-soluble derivative and application of water-soluble derivative |
| 09/04/2013 | CN103272241A Target SERS (Surface Enhanced Raman Scattering) probe with pH-sensitive drug release characteristic, and preparation method thereof |
| 09/04/2013 | CN102604065B Cross-linked biologically degradable carrier polymer, micelle and vesicle, and preparation method and application of the cross-linked biologically degradable carrier polymer, micelle and vesicle |
| 09/04/2013 | CN102526047B Preparing method of model of monkey with chronic systemic Parkinson's disease |
| 09/04/2013 | CN101365495B Composition comprising magnetic iron oxide particles and use thereof in medical imaging |
| 09/03/2013 | US8524865 Antibodies and immunoconjugates and uses therefor |
| 09/03/2013 | US8524784 Polymer micelles containing anthracylines for the treatment of cancer |
| 09/03/2013 | US8524240 Diagnosis and therapy of hematological malignancies |
| 09/03/2013 | US8524239 Photosensitizing antibody-fluorophore conjugates |
| 09/03/2013 | US8524194 Radiolabelled MMP selective compounds |
| 09/03/2013 | US8524193 Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts |
| 08/29/2013 | WO2013126797A1 Cholecystokinin b receptor targeting for imaging and therapy |
| 08/29/2013 | WO2013124444A1 Crosslinked polysaccharide beads comprising an imaging agent |
| 08/29/2013 | US20130224123 Nanoparticulate compositions having lysozyme as a surface stabilizer |
| 08/29/2013 | US20130224122 Magnetotatic bacteria mri positive contract enhancement agent and methods of use |
| 08/29/2013 | US20130224121 Particle containing hydrophobic dye having cyanine structure, and contrast agent containing the particle |
| 08/29/2013 | US20130224120 Multimodal diagnostic technology for early stage cancer lesions |
| 08/29/2013 | US20130224118 Perhexiline for treating chronic heart failure |
| 08/29/2013 | US20130224113 Imaging diagnostics by combining contrast agents |
| 08/28/2013 | CN103263678A Footpad skin tissue optical clearing agent |
| 08/28/2013 | CN102813671B Method for building dextran sodium sulphate (DSS) induced enteritis mouse model |
| 08/28/2013 | CN102614534B Treatment diagnosis preparation based on gold nanoshell coated polymer microcapsule, and preparation method thereof |
| 08/28/2013 | CN101906148B Survivin-derived peptides and use thereof |
| 08/28/2013 | CN101848734B Labelled IIGF binding peptides for imaging |
| 08/27/2013 | US8518893 Medical compositions containing ghrelin |
| 08/27/2013 | US8518393 Fungi transformant for melanin production and uses thereof |
| 08/27/2013 | US8518374 Personal care products with visual indicator of vaginitis |
| 08/27/2013 | US8518372 Coronin 1 modulators for the treatment of autoimmune and Lymphoproliferative disorders and mycobacterial infections |
| 08/22/2013 | WO2013121284A1 Iodinated products intended for a use for the medical imaging and their methods of preparation |
| 08/22/2013 | US20130217857 Erbb interface peptidomimetics and methods of use thereof |
| 08/22/2013 | US20130216481 Use of utp for the diagnosis of stenoses and other conditions of restricted blood flow |
| 08/22/2013 | US20130216480 Amphiphilic polymers and methods of use thereof |
| 08/21/2013 | EP2627361A2 Imaging of meningiomas using phingylbenzothiazole, stilbene, or biphenylalkyne derivatives |
| 08/21/2013 | EP2627360A1 Silica nanoparticles doped with multiple dyes featuring highly efficient energy transfer and tunable stokes-shift |
| 08/21/2013 | CN103260652A Cest systems exhibiting a concentration independent responsiveness |